Calian Group Ltd. · TSX:CGY
Calian — Investor Presentation (September 2026)
18 slides from Calian's investor presentation, Sep 24, 2026
Slide 1: Investor Presentation
Investor Presentation September 24, 2026 © 2026 Calian Group Ltd. 1 1
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac
Slide 3: Calian FY25 Snapshot
3 Calian FY25 Snapshot +40 years 6,000 Ottawa $973M1 CGY History Workforce Head office Market cap TSX Revenue segmentation 33% 67% Essential Defence & Industries Space Customers Geography Offering $774M 48% 44% 25% commercial international products 2025 Revenues 52% 56% 75% government Canadian servi
Slide 4: Solutions for Mission-Critical Industries
Solutions for Mission-Critical Industries AI and digital solutions Cyber solutions Defence Health Space Energy Training and immersive training solutions Engineering and manufacturing solutions Advantage comes from combining capabilities across Continuity and resiliency solutions industries, not stan
Slide 5: Select Customers in Mission-Critical Industries
Select Customers in Mission-Critical Industries Defence Space Health Energy © 2026 Calian Group Ltd. 5
Slide 6: Geographic Footprint
Geographic Footprint 20+ 30+ 6 Offices worldwide Military training Countries locations worldwide 168 5 170+ Ground stations Manufacturing Military healthcare worldwide facilities & clinics locations © 2026 Calian Group Ltd. 6
Slide 7: Snapshot: Track Record of Growth
Snapshot: Track Record of Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 870 120 20.0% 774 325 Gross Profit 299 45.0% Adj. EBITDA Adj. EBITDA Margin 18.0% 101 747 Gross Margin 259 100 659 275 254 40.
Slide 8: Snapshot: Capital Allocation
Snapshot: Capital Allocation Acquisitions Dividends R&D Investments (in millions of $) (in millions of $) (in millions of $) 88 12 12 13 13 13 13 11 66 68 12 10 10 49 39 5 5 24 2021 2022 2023 2024 2025 YTD 2026 2021 2022 2023 2024 2025 YTD 2026 2021 2022 2023 2024 2025 YTD 2026 Capex Share Repurchas
Slide 9: M&A Strategy
M&A Strategy Targeting M&A in mission-critical industries and prioritizing defence and space. Criteria Solutions Size & Price Evaluation ▪ Strategic fit ▪ Enhance & expand ▪ <$100M at historical ▪ IRR >15% ▪ Financial fit (growing & current offering multiples (5x-6x) ▪ Payback 4-6 years accretive ma
Slide 10: Snapshot: Financial Position
Snapshot: Financial Position Total Debt Net Debt1 to Adj. EBITDA1 Credit Facility (in millions of $) (ratio) (in millions of $) 141 350 350 1.1x 131 0.9x Accordion 75 Unused 255 255 150 90 Used 75 75 0.4x 120 120 38 40 40 8 0.1x 0 0.0x 0.0x 2021 2022 2023 2024 2025 Q3 2026 2021 2022 2023 2024 2025 Q
Slide 11: Market Drivers
© 2026 Calian Group Ltd. | Market Drivers Defence Space Health Energy • Global conflicts • Growing satellite launches • Aging demographics • Canadian nuclear energy strategy • Target 5% of GDP spend on defence • Demand for satellite internet • Growth in gig economy • Increased power demand from AI •
Slide 12: Our strategic approach
Our strategic approach Build Calian into a scaled, integrated leader in mission-critical solutions, delivering reliably in the most complex and high-stakes environments Scale Partner Invest Optimize Build scale internally Partner to fill gaps Invest in technology Seek new efficiencies Combine soluti
Slide 13: Our execution to date
Our execution to date Strategic Operational New contracts Partnerships New talent transactions alignment • Acquired Infield Scientific • Launched US subsidiary • Signed undisclosed • Launched Calian • Appointed Major-General focused on defence contracts with NATO & VENTURES (partnerships (Ret.) Roch
Slide 14: High Growth Opportunities: ~70% of Revenues
High Growth Opportunities: ~70% of Revenues Opportunities Calian is well positioned to gain contracts FY25 Revenue Growth Drivers Strategy Competitive Advantage ▪ Global conflicts ▪ Expand existing contracts ▪ Canadian owned and operated company ▪ CAF recruitment ▪ Extend health services to military
Slide 15: Creating Value Per Share for Shareholders
Creating Value Per Share for Shareholders Increasing KPIs per share Adj. EBITDA1/diluted shares OFCF1/diluted shares Adj. EPS1/diluted shares (in $) (in $) (in $) $8.69 $7.68 $6.73 $6.07 $5.98 $6.02 $6.25 $5.28 $4.84 $4.57 $4.48 $4.23 $4.43 $4.15 $3.50 $3.68 $3.37 $3.28 2021 2022 2023 2024 2025 LTM
Slide 16: FY26 Outlook – On track for a record year
FY26 Outlook – On track for a record year Mid/Long Term FY26 10-15% On track Mid-teens Revenue growth target Revenue growth >revenue % Ahead Low 20% Adj. EBITDA1 growth target Adj. EBITDA1 growth © 2026 Calian Group Ltd. 16
Slide 17: Investment Thesis
Investment Thesis 1 Showcasing a Track Record of Execution 2 Investing Capital Strategically 3 Optimizing Capital Structure for Future Growth 4 Capitalizing on Strong Industry Tailwinds 5 Targeting Double-digit Revenue & Adj. EBITDA1 Growth 1 This is a Non-Gaap measure. Please refer to the MD&A. © 2
Slide 18: Thank you
Thank you Jennifer McCaughey, CFA, F.CIRI Director, Investor Relations ir@calian.com © 2026 Calian Group Ltd. 18
Calian Group — Investor Presentation (September 2026) on 6ix